Insulin, Pharmacy Benefit Managers
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S.
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
Rand told lawmakers that for about the past year, health insurance plans and pharmacy benefit managers have been reimbursing ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.